Quick Answer
OPKO HEALTH, INC. reported Total Revenue of $606.88 million for fiscal year 2025.
OPKO HEALTH, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $606.88M -14.9% |
$713.14M -17.4% |
$863.50M -14.0% |
$1.00B -43.4% |
$1.77B +23.6% |
$1.44B +59.1% |
| Revenue (ASC 606) | $606.88M -14.9% |
$713.14M -17.4% |
$863.50M -14.0% |
$1.00B -43.4% |
$1.77B +23.6% |
$1.44B +59.1% |
| Net Income | -$225.68M -324.0% |
-$53.22M +71.8% |
-$188.86M +42.5% |
-$328.40M -989.5% |
-$30.14M -198.6% |
$30.59M +109.7% |
| Diluted EPS | -$0.30 -275.0% |
-$0.08 +68.0% |
-$0.25 +45.7% |
-$0.46 -820.0% |
-$0.05 -200.0% |
$0.05 +109.4% |
| Total Assets | $1.93B -12.2% |
$2.20B +9.4% |
$2.01B -7.2% |
$2.17B -9.7% |
$2.40B -3.0% |
$2.47B +7.1% |
| Cash and Equivalents | — | — | $95.88M -37.4% |
$153.19M +13.7% |
$134.71M +86.6% |
$72.21M -15.5% |
| Stockholders Equity | $1.27B -7.1% |
$1.37B -1.7% |
$1.39B -11.0% |
$1.56B -7.3% |
$1.69B +0.8% |
$1.67B +3.5% |
| R&D Expense | $124.03M +17.9% |
$105.21M +17.4% |
$89.59M +21.3% |
$73.89M -3.9% |
$76.85M +2.0% |
$75.32M -36.1% |
| Operating Income | -$117.41M +22.8% |
-$152.06M +3.2% |
-$157.02M +30.6% |
-$226.25M -1306.7% |
$18.75M -67.5% |
$57.71M +121.1% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | — | — | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $151.67M | -12.6% | -3.3% |
| Revenue (ASC 606) | September 30, 2025 | $151.67M | -12.6% | -3.3% |
| Net Income | September 30, 2025 | $21.63M | -13.1% | +114.6% |
| Diluted EPS | September 30, 2025 | $0.03 | +0.0% | +115.8% |
| Total Assets | September 30, 2025 | $2.00B | -11.6% | +1.1% |
| Cash and Equivalents | June 30, 2024 | $40.58M | -62.5% | -46.4% |
| Stockholders Equity | September 30, 2025 | $1.31B | -7.0% | +0.7% |
| R&D Expense | September 30, 2025 | $30.08M | +4.5% | -0.9% |
| Operating Income | September 30, 2025 | $48.06M | +238.0% | +180.1% |
| Gross Profit | March 31, 2013 | $19.62M | +417.7% | +355.4% |
| Shares Outstanding | June 30, 2011 | 287.95M | — | +12.7% |
- OPKO HEALTH, INC. reported Total Revenue of $606.88 million for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -14.9% in Total Revenue compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Revenue (ASC 606) of $606.88 million for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -14.9% in Revenue (ASC 606) compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Net Income of -$225.68 million for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -324.0% in Net Income compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Diluted EPS of $0.30 per share (loss) for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -275.0% in Diluted EPS compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Total Assets of $1.93 billion for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -12.2% in Total Assets compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Cash and Equivalents of $95.88 million for fiscal year 2023.
- OPKO HEALTH, INC. showed a decrease of -37.4% in Cash and Equivalents compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Stockholders Equity of $1.27 billion for fiscal year 2025.
- OPKO HEALTH, INC. showed a decrease of -7.1% in Stockholders Equity compared to the prior fiscal year.
- OPKO HEALTH, INC. reported R&D Expense of $124.03 million for fiscal year 2025.
- OPKO HEALTH, INC. showed an increase of +17.9% in R&D Expense compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Operating Income of -$117.41 million for fiscal year 2025.
- OPKO HEALTH, INC. showed an increase of +22.8% in Operating Income compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Gross Profit of $19.17 million for fiscal year 2012.
- OPKO HEALTH, INC. showed an increase of +78.5% in Gross Profit compared to the prior fiscal year.
- OPKO HEALTH, INC. reported Shares Outstanding of 297.50 million shares for fiscal year 2012.
- OPKO HEALTH, INC. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: